Metoclopramide for Avoiding Pneumonia after Stroke (MAPS-2) Trial
(2023)
Presentation / Conference
Roffe, C., Warusevitane, A., Smith, C., Dixit, A., Sprigg, N., Ogollah, R., …Bath, P. (2023, October). Metoclopramide for Avoiding Pneumonia after Stroke (MAPS-2) Trial. Poster presented at 15th World Stroke Congress, Toronto, Canada
The research study is designed to assess a treatment which might prevent pneumonia and improve survival in patients that have had a stroke. Pneumonia is a major cause of death after stroke and delays recovery in survivors. The most important cause o... Read More about Metoclopramide for Avoiding Pneumonia after Stroke (MAPS-2) Trial.